These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2406450)

  • 21. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Ambrus JL; Ambrus CM; Gastpar H
    Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
    [No Abstract]   [Full Text] [Related]  

  • 22. A model for metastases formation.
    Markovitch S
    Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.
    Tanigawa N; Mizuno Y; Hashimura T; Honda K; Satomura K; Hikasa Y; Niwa O; Sugahara T; Yoshida O; Kern DH
    Cancer Res; 1984 Jun; 44(6):2309-12. PubMed ID: 6202397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug resistance and implication for therapy].
    Tsuruo T
    Rinsho Ketsueki; 1989 Aug; 30(8):1128-32. PubMed ID: 2574754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance of cancer cells to antineoplastic agents. Can the efficiency of chemotherapy be predicted?].
    Bénard J
    Rev Prat; 1992 Feb; 42(3):318-9. PubMed ID: 1579821
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer.
    Lalani AS; Alters SE; Wong A; Albertella MR; Cleland JL; Henner WD
    Clin Cancer Res; 2007 Apr; 13(7):2216-25. PubMed ID: 17404106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.
    Zheng P; Wang Q; Teng J; Chen J
    Pharmacol Res; 2015 Sep; 99():11-5. PubMed ID: 25976680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming tumour radiation resistance resulting from acute hypoxia.
    Horsman MR; Overgaard J
    Eur J Cancer; 1992; 28A(4-5):717-8. PubMed ID: 1524887
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pim-1 induced by hypoxia is involved in drug resistance and tumorigenesis of solid tumor cells].
    Teh BG
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):19-26. PubMed ID: 14978971
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiation induction of drug resistance in RIF-1 tumors and tumor cells.
    Hopwood LE; Moulder JE
    Radiat Res; 1989 Nov; 120(2):251-66. PubMed ID: 2616741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms underlying hypoxia development in tumors.
    Dewhirst MW
    Adv Exp Med Biol; 2003; 510():51-6. PubMed ID: 12580404
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypoxia and Noncoding RNAs in Taxane Resistance.
    Pucci P; Rescigno P; Sumanasuriya S; de Bono J; Crea F
    Trends Pharmacol Sci; 2018 Aug; 39(8):695-709. PubMed ID: 29891252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor oxygenation and its relevance to tumor physiology and treatment.
    Vaupel P; Höckel M
    Adv Exp Med Biol; 2003; 510():45-9. PubMed ID: 12580403
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acquisition of resistance to suramin in the cells of fibrosarcoma in Chinese hamsters accompanied by morphologic modification and increased metastatic capacity].
    Lelièvre S; Larsen AK
    Bull Cancer; 1994 Oct; 81(10):903-5. PubMed ID: 7734777
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases.
    Daneau G; Boidot R; Martinive P; Feron O
    Clin Cancer Res; 2010 Jan; 16(2):410-9. PubMed ID: 20068092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
    Rofstad EK; Galappathi K; Mathiesen B; Ruud EB
    Clin Cancer Res; 2007 Apr; 13(7):1971-8. PubMed ID: 17360973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry.
    Goodale D; Phay C; Postenka CO; Keeney M; Allan AL
    Cytometry A; 2009 Apr; 75(4):344-55. PubMed ID: 18855920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer metastasis and the use of animal model systems.
    Schirrmacher V
    Behring Inst Mitt; 1984 May; (74):195-200. PubMed ID: 6206842
    [No Abstract]   [Full Text] [Related]  

  • 40. [Temperature dependence of cytostatic drug effect. Metabolic milieu and tumor oxygenation with hyperthermia].
    Wiedemann GJ
    Fortschr Med; 1995 Apr; 113(11):166. PubMed ID: 7768480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.